Evidence map›Paper›PMID 42862287›Full record

ReviewDermatologie (Heidelberg, Germany)2026

[Current dermatology guidelines in Germany: selected clinically relevant recommendations].

Antonia Pennitz, Mark Berneburg, Ulrike Blume-Peytavi, Manigé Fartasch, Tobias Görge, Gudula Kirtschig, Christoph R Löser, Peter Mayser, Rotraut Mößner, Cord Sunderkötter and 4 more

Abstract readEnglish AbstractReview
PubMed Publisher
In one paragraph

Review in Dermatologie (Heidelberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Antonia PennitzKlinik für Dermatologie, Venerologie und Allergologie, Division of Evidence Based Medicine in Dermatology (dEBM), Charité - Universitätsmedizin Berlin, Gliedkörperschaft der Freien Universität Berlin und der Humboldt-Universität zu Berlin, Berlin, Deutschland.
Mark BerneburgKlinik und Poliklinik für Dermatologie, Universitätsklinikum Regensburg, Regensburg, Deutschland.
Ulrike Blume-PeytaviKlinik für Dermatologie, Venerologie und Allergologie, Clinical Research Center for Hair and Skin Science (CRC), Charité - Universitätsmedizin Berlin, Gliedkörperschaft der Freien Universität Berlin und der Humboldt-Universität zu Berlin, Berlin, Deutschland.
Manigé FartaschInstitut für Prävention und Arbeitsmedizin der DGUV, Institut der Ruhr-Universität Bochum (IPA), Bereich für klinische und experimentelle Berufsdermatologie, Bochum, Deutschland.
Tobias GörgeKlinik und Poliklinik für Hautkrankheiten, Universitätsklinikum Münster, Münster, Deutschland.
Gudula KirtschigMedbase Health Centre Frauenfeld, Frauenfeld, Schweiz.
Christoph R LöserHautklinik, Hauttumorzentrum, Klinikum der Stadt Ludwigshafen am Rhein gGmbH, Bremserstr. 79, 67063, Ludwigshafen am Rhein, Deutschland.
Peter Mayser, Biebertal, Deutschland.
Rotraut MößnerKlinik für Dermatologie, Venerologie und Allergologie, Universitätsmedizin Göttingen, Göttingen, Deutschland.
Cord SunderkötterUniversitätsklinik und Poliklinik für Dermatologie und Venerologie, Universitätsklinikum Halle (Saale), Halle, Deutschland.
Athanasios TsianakasKlinik für Dermatologie und Allergologie, Fachklinik Bad Bentheim, Bad Bentheim, Deutschland.
Ricardo Niklas WernerKlinik für Dermatologie, Venerologie und Allergologie, Division of Evidence Based Medicine in Dermatology (dEBM), Charité - Universitätsmedizin Berlin, Gliedkörperschaft der Freien Universität Berlin und der Humboldt-Universität zu Berlin, Berlin, Deutschland.
Margitta WormKlinik für Dermatologie, Venerologie und Allergologie, Division of Allergy and Immunology, Charité - Universitätsmedizin Berlin, Gliedkörperschaft der Freien Universität Berlin und der Humboldt-Universität zu Berlin, Berlin, Deutschland.
Alexander NastKlinik für Dermatologie, Venerologie und Allergologie, Division of Evidence Based Medicine in Dermatology (dEBM), Charité - Universitätsmedizin Berlin, Gliedkörperschaft der Freien Universität Berlin und der Humboldt-Universität zu Berlin, Berlin, Deutschland. debm01@charite.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dermatological guidelines represent an essential foundation for evidence-based diagnosis, treatment, and prevention of skin diseases. In Germany, they are primarily developed under the leadership of the German Dermatological Society (DDG) in collaboration with the Professional Association of German Dermatologists (BVDD), in accordance with the methodological standards of the Association of the Scientific Medical Societies in Germany (AWMF), and are regularly updated. In 2025 and 2026, numerous new or substantially revised guidelines were published, covering a broad spectrum of dermatological diseases. These include both common chronic inflammatory dermatoses and rare diseases, infectious conditions, occupational dermatoses, autoimmune skin disorders, as well as rehabilitative and diagnostic care concepts. The aim of this review is to provide a practice-oriented summary of selected, newly published or updated German guidelines from this period that are of particular clinical relevance to patient care. The selection focused on guidelines addressing substantial innovations in diagnosis or treatment, as well as those addressing common or clinically challenging diseases. As the selected guidelines cover different development levels, they differ in terms of methodology and evidence synthesis. The review therefore focuses on clinically relevant innovations and practical recommendations. Regardless of the respective development level, individual adaptation of each guideline recommendation to the specific patient situation remains essential.

Indexed as

Clinical decision-makingDermatologyEvidence-based medicineHealthcareSkin

Identifiers

PMID42862287

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.